Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA T… Pending

2024-520093-34-00 Acinar cell prostatic carcinoma 5
Administration of Gilteritinib to eliminate MRD in patients with AML and FLT3-ITD mutation. Pending

2025-521875-30-00 Acute myeloid leukaemia 4
Trametinib in neurofibromatosis type 1 related symptomatic plexiform neurofibromas Pending

2024-516593-30-00 Neurofibromatosis type 1 4
CHILURSO: Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy Pending

2025-521317-50-00 Cholestatic hepatitis induced by immune checkpoint inhi 5
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who ar… Pending

2026-525543-32-00 Recurrent glioblastoma 3
DUAL Pending

2023-505453-40-00 Prostate cancer 7
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma Pending

2025-522523-96-00 T-cell Non-Hodgkin Lymphoma 1
TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma: A single-arm Phas… Pending

2024-516182-37-01 Maintenance treatment in patients with locally advanced 4
ProFertil Pending

2024-518977-32-00 Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and n 5
AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors… Pending

2025-524056-63-00 microsatellite instability high/mismatch repair deficie 1
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Pending

2024-510617-15-00 Non-metastatic resectable pancreatic cancer 5
Impact of the timing of immunotherapy administration in metastatic lung cancers Pending

2025-521891-78-00 Adult patients with stage IV non squamous non-small cel 5
Phase II study of dornase alpha and cisplatin in germ cell cancer. Pending

2023-510135-10-00 germ cell cancer 4
68Ga/177Lu-PSMA theranostics in recurrent grade 3 and grade 4 glioma Pending

2024-518495-31-00 Recurrent grade 3 and grade 4 glioma 4
Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed sma… Pending

2025-521902-17-00 Unresectable/metastatic Small cell Lung Cancer (SCLC) 9
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors Pending

2025-523232-39-00 Advanced Solid Tumors 1
Phase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer. Pending

2024-514001-65-00 Non-Small Cell Lung Cancer 3
Statins to Prevent Immune checkpoint inhibitor-induced pRogression of AtheroscLerosis Pending

2024-511127-33-00 Atherosclerosis 6
Cannabis extrAct in oncology Patients for the treatment of TUmor Related symptom burden (CAPTURE) Pending

2024-519568-42-00 Patients with advanced oncologic disease receiving acti 4
A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia… Pending

2025-523238-17-00 Acute myeloid leukemia 4
Study of Antibiotic Combinations in Early Breast Cancer Pending

2024-517993-94-00 Breast Cancer 4
A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute M… Pending

2024-520125-36-00 Relapsed or Refractory Acute Myeloid Leukemia; Acute M 3
IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after… Pending

2025-521908-22-00 EGFR-mutated Non-small Cell Lung Cancer 10
Maintenance AVElumab after SECond line platinum-based chemotherapy for metastatic urothelial carcinoma: AVESEC trial – GOIRC-02-2025 Pending

2025-524077-16-00 metastatic urothelial carcinoma 4